Description
Taylor & Francis Sirolimus-Eluting Stents From Research to Clinical Practice 2004 Edition by Patrick W. Serruys, Pedro A. Lemos
Recently, sirolimus-eluting stents implantation has been shown to decrease restenosis markedly in selected patients. Nonetheless, the effects of SES implantation in complex, unselected patients, such as those commonly treated in daily practice ('the real world'), remains largely unknown. This book comprehensively evaluates the impact of SES implantation on the outcomes of patients treated in the real world of interventional cardiology. The authors have evaluated in detail the short- and long-term outcomes of several high-risk subsets not currently included in randomized trials. While it is specific to sirolimus, the book covers the major competing drug eluting stents, including paclitaxel. Table of contents : - SIROLIMUS-ELUTING STENTS IN THE CLINICAL PRACTICE: CONCEPTS AND GENERAL OVERVIEWSirolimus-Eluting Stents as an Anti-Restenosis Device: Basic Concepts and Summary of Pivotal Studies, P.W. Serruys and P.A. LemosSirolimus-Eluting Stents in the "Real World": The RESEARCH Registry Rationale and Study Design, P.A. Lemos, P.W. Serruys, and R.T. van DomburgUnrestricted Utilization of Sirolimus-Eluting Stents for de Novo Coronary Lesions, P.A. Lemos, P.W. Serruys, and R.T. van DomburgSIROLIMUS-ELUTING STENTS FOR PATIENTS AT HIGH CLINICAL RISKEarly Safety of Sirolimus-Eluting Stents for Patients with Acute Coronary Syndromes, P.A. Lemos, C-h. Lee, and P.W. SerruysSirolimus-Eluting Stents for Patients with Acute Myocardial Infarction, F. Saia, P.A. Lemos, and P.W. SerruysSirolimus-Eluting Stents for Patients with Impaired Renal Function, P.A. Lemos, R.T. van Domburg, and P.W. SerruysSirolimus-Eluting Stents for Patients with Prior Coronary Bypass Graft Surgery, A. Hoye and P.W. SerruysSirolimus-Eluting Stents for Main Left Coronary Artery Disease, C.A. Arampatzis and P.W. SerruysSirolimus-Eluting Stents for Patients with Multivessel Coronary Disease, C.A. Arampatzis and P.A. LemosSirolimus-Eluting Stents for Elderlies, M. Vijayakumar, P.A. Lemos, and P.W. SerruysSIROLIMUS-ELUTING STENTS FOR PATIENTS AT SPECIAL ANATOMIC GROUPSSirolimus-Eluting Stents for Chronic Total Occlusions, A. Hoye, K. Tanabe, and P.W. SerruysSirolimus-Eluting Stents for Very Small Coronary Vessels, P.A. Lemos and P.W. SerruysSirolimus-Eluting Stents for Very Long Lesions, M. Degertekin, C.A. Arampatzis, and P.A. LemosSirolimus-Eluting Stents for Bifurcation Lesions, K. Tanabe, A. Hoye, and P.W. SerruysSirolimus-Eluting Stents for Coronary Narrowings